Skip to main content

Correction: Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis

The Original Article was published on 19 July 2022

Correction: BMC Cancer 22, 792 (2022)

https://doi.org/10.1186/s12885-022-09816-6

Following publication of the original article [1], the authors identified a typesetting error. Figure 2 was published in incomplete form. Figure 2E-G were erroneously omitted. The complete Fig. 2 has been published in this correction. The original article [1] has been updated.

Fig. 2
figure 1

Forest plots of altered metabolites identified in meta-analysis (A) Forest plot of 19 metabolomic studies using AUC values and computed standard error. Heterogeneity (I2) was assessed for fixed and random effects (B) Forest plot of lipid metabolites retrieved from 11 studies (C) Forest plot of carbohydrate metabolites retrieved from 6 studies (D) Forest plot of amino acid metabolites retrieved from 13 studies. Metabolic pathway analysis using metaboAnalyst identified (E) Enriched glycerophospholipid pathway for circulatory metabolites detected in healthy control and PDAC. Metabolites marked in red are altered in PDAC patients as compared to healthy controls (F) metaboAnalyst analysis identified enriched arginine and glutamate metabolism for circulatory metabolites detected in PDAC as compared to healthy controls/chronic pancreatitis. Metabolites are marked in red and their fold changes are in blue color (G) metaboAnalyst analysis identified enriched sphingomyelin pathway and TCA cycle for circulatory metabolites detected in PDAC and CP patients. Metabolites are marked in red and their fold changes are in blue color

Reference

  1. Ketavarapu V, Ravikanth V, Sasikala M, et al. Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis. BMC Cancer. 2022;22:792. https://doi.org/10.1186/s12885-022-09816-6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitnala Sasikala.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ketavarapu, V., Ravikanth, V., Sasikala, M. et al. Correction: Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis. BMC Cancer 22, 825 (2022). https://doi.org/10.1186/s12885-022-09920-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-09920-7